These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20561165)

  • 1. Testosterone levels in males with type 2 diabetes and their relationship with cardiovascular risk factors and cardiovascular diseases.
    Li H; Kong XB; Zhang HL; Wu J
    J Sex Med; 2011 Apr; 8(4):1260. PubMed ID: 20561165
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus.
    Ogbera OA; Sonny C; Olufemi F; Wale A
    J Coll Physicians Surg Pak; 2011 Sep; 21(9):517-21. PubMed ID: 21914405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypogonadotropic hypogonadism in men with type 2 diabetes.
    Dandona P; Dhindsa S; Chandel A; Chaudhuri A
    Postgrad Med; 2009 May; 121(3):45-51. PubMed ID: 19491539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone levels in males with type 2 diabetes and their relationship with cardiovascular risk factors and cardiovascular disease.
    Hernández-Mijares A; García-Malpartida K; Solá-Izquierdo E; Bañuls C; Rocha M; Gómez-Martínez MJ; Mármol R; Víctor VM
    J Sex Med; 2010 May; 7(5):1954-64. PubMed ID: 20214724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum testosterone levels and features of the metabolic syndrome defining criteria in patients with type 2 diabetes mellitus.
    Ogbera AO
    West Afr J Med; 2011; 30(4):277-81. PubMed ID: 22669833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.
    Kapoor D; Aldred H; Clark S; Channer KS; Jones TH
    Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Aktuelle Urol; 2015 Jan; 46(1):15-6. PubMed ID: 25658228
    [No Abstract]   [Full Text] [Related]  

  • 8. Testosterone and mortality.
    Muraleedharan V; Jones TH
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):477-87. PubMed ID: 25041142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relevant clinical and biological criteria for the diagnosis of androgen deficiency in the aging male (ADAM)].
    Seisen T; Rouprêt M; Gallais JL; Costa P
    Prog Urol; 2012 Jun; 22 Suppl 1():S21-6. PubMed ID: 22770497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone and cardiovascular risk factors.
    Cohen PG
    Arch Intern Med; 2000 Jul; 160(13):2064-5. PubMed ID: 10888987
    [No Abstract]   [Full Text] [Related]  

  • 11. Low testosterone syndrome protects subjects with high cardiovascular risk burden from major adverse cardiovascular events.
    Corona G; Rastrelli G; Maseroli E; Fralassi N; Sforza A; Forti G; Mannucci E; Maggi M
    Andrology; 2014 Sep; 2(5):741-7. PubMed ID: 25044637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes mellitus and testosterone: a meta-analysis study.
    Corona G; Monami M; Rastrelli G; Aversa A; Sforza A; Lenzi A; Forti G; Mannucci E; Maggi M
    Int J Androl; 2011 Dec; 34(6 Pt 1):528-40. PubMed ID: 20969599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related androgen deficiency and type 2 diabetes.
    Ryan GJ; Jobe LJ
    J Pharm Pract; 2011 Jun; 24(3):316-22. PubMed ID: 21676855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low testosterone and the association with type 2 diabetes.
    Farrell JB; Deshmukh A; Baghaie AA
    Diabetes Educ; 2008; 34(5):799-806. PubMed ID: 18832284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
    Mulligan T; Frick MF; Zuraw QC; Stemhagen A; McWhirter C
    Int J Clin Pract; 2006 Jul; 60(7):762-9. PubMed ID: 16846397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus.
    Costanzo PR; Suárez SM; Scaglia HE; Zylbersztein C; Litwak LE; Knoblovits P
    Andrology; 2014 Jan; 2(1):117-24. PubMed ID: 24282162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The determination of total testosterone and free testosterone (RIA) are not applicable to the evaluation of gonadal function in HIV-infected males.
    Moreno-Pérez O; Escoín C; Serna-Candel C; Portilla J; Boix V; Alfayate R; González-Sánchez V; Mauri M; Sánchez-Payá J; Picó A
    J Sex Med; 2010 Aug; 7(8):2873-83. PubMed ID: 20626606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies.
    Shivananda Nayak B; Teelucksingh S; Jagessar A; Maharaj S; Maharaj N
    Diabetes Metab Syndr; 2013; 7(1):8-11. PubMed ID: 23517788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes.
    Bhatia V; Chaudhuri A; Tomar R; Dhindsa S; Ghanim H; Dandona P
    Diabetes Care; 2006 Oct; 29(10):2289-94. PubMed ID: 17003308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male hypogonadism. Part I: Epidemiology of hypogonadism.
    Seftel AD
    Int J Impot Res; 2006; 18(2):115-20. PubMed ID: 16193071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.